X

Xenon Pharmaceuticals

XENE

43.790
USD
0.63
(1.46%)
مغلق
حجم التداول
7,526
الربح لكل سهم
0
العائد الربحي
0
P/E
-16
حجم السوق
3,238,174,944
أصول ذات صلة
A
ADVM
0.09000
(1.21%)
7.53000 USD
B
BMRN
0.270
(0.32%)
84.620 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
REGN
13.14
(1.22%)
1,091.19 USD
R
RPRX
0.350
(1.24%)
28.510 USD
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.